Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
60,700
-3,000 (-4.71%)
At close: Apr 28, 2026

Next Biomedical Revenue

In the year 2025, Next Biomedical had annual revenue of 16.48B KRW with 72.67% growth. Next Biomedical had revenue of 3.80B in the quarter ending December 31, 2025, with 70.60% growth.

Revenue
16.48B
Revenue Growth
+72.67%
P/S Ratio
30.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
497.98B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202516.48B6.93B72.67%
Dec 31, 20249.54B4.66B95.46%
Dec 31, 20234.88B2.09B74.67%
Dec 31, 20222.80B527.74M23.28%
Dec 31, 20212.27B6.63M0.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ASTERASYS Co.,Ltd 37.94B
MEDIANA Co.,Ltd 64.94B
L&K Biomed 38.92B
SELVAS Healthcare 30.82B
Remed 24.50B
Noul Co.,Ltd. 5.12B
QuantaMatrix 3.69B
Neofect 16.05B
Revenue Rankings